Profiel
Diane Tang-Liu is the founder of AiViva BioPharma, Inc., which she founded in 2015 and where she currently holds the titles of President, Chief Executive Officer & Director.
She is also currently the President, Chief Executive Officer & Director of AiViva Holding Ltd.
Actieve functies van Diane Tang-Liu
| Bedrijven | Functie | Begin |
|---|---|---|
AiViva Holding Ltd.
 AiViva Holding Ltd. Financial ConglomeratesFinance AiViva Holding Ltd. functions as an investment holding company. The company is based in Newport Beach, CA. The CEO of the company is Diane Tang-Liu. | Algemeen Directeur | - |
Aiviva Biopharma, Inc.
 Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | Oprichter | 01-01-2015 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
AiViva Holding Ltd.
AiViva Holding Ltd. Financial ConglomeratesFinance AiViva Holding Ltd. functions as an investment holding company. The company is based in Newport Beach, CA. The CEO of the company is Diane Tang-Liu. | Finance |
Aiviva Biopharma, Inc.
Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | Health Technology |